Literature DB >> 23348503

TERT promoter mutations in familial and sporadic melanoma.

Susanne Horn1, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki, Dirk Schadendorf, Rajiv Kumar.   

Abstract

Cutaneous melanoma occurs in both familial and sporadic forms. We investigated a melanoma-prone family through linkage analysis and high-throughput sequencing and identified a disease-segregating germline mutation in the promoter of the telomerase reverse transcriptase (TERT) gene, which encodes the catalytic subunit of telomerase. The mutation creates a new binding motif for Ets transcription factors and ternary complex factors (TCFs) near the transcription start and, in reporter gene assays, caused up to twofold increase in transcription. We then screened the TERT promoter in sporadic melanoma and observed recurrent ultraviolet signature somatic mutations in 125 of 168 (74%) of human cell lines derived from metastatic melanomas, 45 of 53 corresponding metastatic tumor tissues (85%), and 25 of 77 (33%) primary melanomas. The majority of those mutations occurred at two positions in the TERT promoter and also generated binding motifs for Ets/TCF transcription factors.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23348503     DOI: 10.1126/science.1230062

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  771 in total

1.  Modeling Genomic Instability and Selection Pressure in a Mouse Model of Melanoma.

Authors:  Lawrence N Kwong; Lihua Zou; Sharmeen Chagani; Chandra Sekhar Pedamallu; Mingguang Liu; Shan Jiang; Alexei Protopopov; Jianhua Zhang; Gad Getz; Lynda Chin
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

2.  Paradoxical prognostic impact of TERT promoter mutations in gliomas depends on different histological and genetic backgrounds.

Authors:  Hao You; Yao Wu; Kai Chang; Xiao Shi; Xin-Da Chen; Wei Yan; Rui Li
Journal:  CNS Neurosci Ther       Date:  2017-09-03       Impact factor: 5.243

3.  Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

Authors:  Yinghui Li; Qi-Ling Zhou; Wenjie Sun; Prashant Chandrasekharan; Hui Shan Cheng; Zhe Ying; Manikandan Lakshmanan; Anandhkumar Raju; Daniel G Tenen; Shi-Yuan Cheng; Kai-Hsiang Chuang; Jun Li; Shyam Prabhakar; Mengfeng Li; Vinay Tergaonkar
Journal:  Nat Cell Biol       Date:  2015-09-21       Impact factor: 28.824

4.  IW-Scoring: an Integrative Weighted Scoring framework for annotating and prioritizing genetic variations in the noncoding genome.

Authors:  Jun Wang; Abu Z Dayem Ullah; Claude Chelala
Journal:  Nucleic Acids Res       Date:  2018-05-04       Impact factor: 16.971

5.  Histologic features of melanoma associated with germline mutations of CDKN2A, CDK4, and POT1 in melanoma-prone families from the United States, Italy, and Spain.

Authors:  Michael R Sargen; Donato Calista; David E Elder; Daniela Massi; Emily Y Chu; Míriam Potrony; Ruth M Pfeiffer; Cristina Carrera; Paula Aguilera; Llucia Alos; Susana Puig; Rosalie Elenitsas; Xiaohong R Yang; Margaret A Tucker; Maria Teresa Landi; Alisa M Goldstein
Journal:  J Am Acad Dermatol       Date:  2020-04-10       Impact factor: 11.527

Review 6.  Genetics of metastasis: melanoma and other cancers.

Authors:  Noel Turner; Olivia Ware; Marcus Bosenberg
Journal:  Clin Exp Metastasis       Date:  2018-05-02       Impact factor: 5.150

7.  Promoting a new brain tumor mutation: TERT promoter mutations in CNS tumors.

Authors:  Zachary J Reitman; Christopher J Pirozzi; Hai Yan
Journal:  Acta Neuropathol       Date:  2013-12       Impact factor: 17.088

8.  Genetic diagnosis of a Chinese multiple endocrine neoplasia type 2A family through whole genome sequencing.

Authors:  Zhen-Fang DU; Peng-Fei Li; Jian-Qiang Zhao; Zhi-Lie Cao; Feng Li; Ju-Ming Ma; Xiao-Ping Qi
Journal:  J Biosci       Date:  2017-06       Impact factor: 1.826

Review 9.  [Molecular diagnostics of melanomas].

Authors:  K G Griewank
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

10.  Integrative annotation of variants from 1092 humans: application to cancer genomics.

Authors:  Ekta Khurana; Yao Fu; Vincenza Colonna; Xinmeng Jasmine Mu; Hyun Min Kang; Tuuli Lappalainen; Andrea Sboner; Lucas Lochovsky; Jieming Chen; Arif Harmanci; Jishnu Das; Alexej Abyzov; Suganthi Balasubramanian; Kathryn Beal; Dimple Chakravarty; Daniel Challis; Yuan Chen; Declan Clarke; Laura Clarke; Fiona Cunningham; Uday S Evani; Paul Flicek; Robert Fragoza; Erik Garrison; Richard Gibbs; Zeynep H Gümüş; Javier Herrero; Naoki Kitabayashi; Yong Kong; Kasper Lage; Vaja Liluashvili; Steven M Lipkin; Daniel G MacArthur; Gabor Marth; Donna Muzny; Tune H Pers; Graham R S Ritchie; Jeffrey A Rosenfeld; Cristina Sisu; Xiaomu Wei; Michael Wilson; Yali Xue; Fuli Yu; Emmanouil T Dermitzakis; Haiyuan Yu; Mark A Rubin; Chris Tyler-Smith; Mark Gerstein
Journal:  Science       Date:  2013-10-04       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.